Not type of induction therapy but consolidation with allogeneic hematopoietic cell transplantation determines outcome in older AML patients: A single center experience of 355 consecutive patients
Open Access
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 80, 33-39
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Myelodysplastic Syndromes and Acute Myeloid Leukemia in the ElderlyClinics in Geriatric Medicine, 2016
- Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989–2012Leukemia, 2015
- Azacitidine in AML: a treatment option?Blood, 2015
- Management of older or unfit patients with acute myeloid leukemiaLeukemia, 2014
- Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemiaBlood, 2013
- Therapeutic Advances in Acute Myeloid LeukemiaJournal of Clinical Oncology, 2011
- AML at older age: age-related gene expression profiles reveal a paradoxical down-regulation of p16INK4A mRNA with prognostic significanceBlood, 2009
- Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia RegistryBlood, 2009
- The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia.British Journal of Haematology, 2007
- Age and acute myeloid leukemiaBlood, 2006